glp 1 and gip function The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Figure 2 from Glucagon-like peptide-1,

GCGR/CRE Luciferase Reporter HEK293 Cell Line GCGR/CRE Luciferase Reporter HEK293 Cell Line is a HEK293 cell line that expresses the firefly luciferase reporter, under the control of the cAMP response element (CRE), and human GCGR (Glucagon receptor

While this might seem counterintuitive since glucagon raises blood glucose, the combined effect with GLP-1 and GIP agonism keeps glucose levels in check while dramatically increasing the metabolic rate

Why tracking can help, and when it backfires A simple sleep diary can show patterns fast

This table outlines their typical use cases, advantages, drawbacks, and bioavailability

*SURMOUNT-1, 72-week study of adults with obesity using Zepbound (tirzepatide 15mg)

Microdosing isnt a magic bullet